cognitive cybersecurity intelligence

News and Analysis

Search

Amazon pulls several eyedrops after FDA warning

Amazon is removing seven eye drop products from its platform, following a warning from the US Food and Drug Administration (FDA). The FDA says the products are not FDA-approved and pose a public health risk. The products include Similasan Pink Eye Relief, The Goodbye Company Pink Eye, Can-C Eye Drops, among others. This comes after the FDA warned against usage of 26 over-the-counter eye drops last month due to the risk of eye infections.

Source: thehill.com –

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts